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Background. Tuberculosis (TB) remains a global public health problem with known gender-related disparities. We reviewed
the quantitative evidence for gender-related differences in accessing TB services from symptom onset to treatment initiation.
Methods.Followingasystematicreviewprocess,we:searched12electronicdatabases;includedquantitativestudiesassessinggender
differences in accessing TB diagnostic and treatment services; abstracted data; and assessed study validity. We defined barriers and
delays at the individual and provider/system levels using a conceptual framework of the TB care continuum and examined gender-
related differences. Results. Among 13,448 articles, 137 were included: many assessed individual-level barriers (52%) and delays
(42%), 76% surveyed persons presenting for care with diagnosed or suspected TB, 24% surveyed community members, and two-
thirds were from African and Asian regions. Many studies reported no gender differences. Among studies reporting disparities,
women faced greater barriers (financial: 64% versus 36%; physical: 100% versus 0%; stigma: 85% versus 15%; health literacy: 67%
versus 33%; and provider-/system-level: 100% versus 0%) and longer delays (presentation to diagnosis: 45% versus 0%) than men.
Conclusions. Many studies found no quantitative gender-related differences in barriers and delays limiting access to TB services.
When differences were identified, women experienced greater barriers and longer delays than men.
1. Introduction
Tuberculosis (TB) remains a significant global public health
issue. Significantly, the TB disease burden is unequally dis-
tributed among men and women. Of the estimated 8.7
million incident TB cases and 1.4 million deaths caused
by TB globally in 2011, roughly one-third occurred among
women(2.9millionincidentTBcasesand0.5milliondeaths)
[1]. Currently, it is unclear whether these disparities are
due to sex-related differences (i.e., biology), gender-based
differences (i.e., sociocultural practices and different social
roles of men and women), or both [2–4]. Until recently,
gender-related differences in the epidemiology, diagnosis,
treatment, outcomes, and socioeconomic costs of TB have
received relatively little attention. To address this knowledge
gap, the World Health Organization (WHO) has proposed a
framework and priorities for research on gender and TB [5].
To date, gender-based research supports that men and
women respond differently to illness and face different
barriers when accessing TB diagnostic and treatment ser-
vices [2]. Barriers that limit access to TB services occur at
the individual and provider/system levels. Individual-level
barriers involve physical (distance to TB services and access
to transport), financial (the direct and indirect costs of
seeking TB services), stigma (stigma surrounding TB and its
associationwithHIV),healthliteracy(TB-relatedknowledge
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and education), and sociocultural (gender roles and status
in the family) factors, whereas provider/system-level barriers
include provider degree of suspicion for TB, the number
and types of providers seen before TB diagnosis, provider
adherence to national TB program guidelines, and patient
satisfaction with TB services. A comprehensive understand-
ing of gender-related differences in barriers and delays at
each level is needed so that researchers and policymakers
can formulate and prioritize gender-specific interventions to
improve the global impact of TB services.
Although several reviews have examined gender-related
barriers and delays in seeking TB care [2, 3, 6–11], none have
simultaneouslyassessedthecontributionofbothbarriersand
delaysinasystematicmanner.Furthermore,previousreviews
have assessed a narrow study population. Currently, no
review has captured the full continuum of TB care by includ-
ing studies that have surveyed the general population, high-
risk populations (e.g., homeless or HIV-infected persons),
TB suspects who may not have sought care (e.g., untreated
individuals with chest symptoms in the community), and TB
patients and suspects presenting for care.
Our review aims to address these limitations. Using a
partially-adopted, published framework [5], we systemat-
ically reviewed the literature to examine the quantitative
evidence for gender-related differences in the barriers and
delays that limit access to TB services along the continuum
of care from symptom onset to treatment initiation. In this
report, we present the findings from our quantitative review,
which have important implications for TB service programs,
research, and policymakers alike.
2. Methods
2.1. Systematic Review Process
2.1.1. Search Strategy. We searched 12 electronic databases
for human and English articles published between Jan-
uary 1953 and October 2010. We developed our search
strategy for MEDLINE using PubMed with a combina-
tion of controlled vocabulary and keyword terms and
phrases (see Supplementary Material available online at
http://dx.doi.org/10.1155/2014/461935). The strategy was then
translated for the Excerpta Medica Database (EMBASE), the
Cumulative Index to Nursing and Allied Health Literature
(CINAHL), Global Health, Popline, Africa Wide, LILACS,
Web of Science, and the inclusive databases of the Cochrane
Library using their respective thesaurus terms, synonyms,
and keywords. Citations from each database were imported
into a reference management system, and duplicates were
removed.
2.1.2.StudySelectionCriteria. Weincludedquantitativestud-
ies that reported on gender-related differences in barriers
to and/or delays in accessing TB diagnostic and treatment
services and studied human participants aged 15 years or
older. Studies that did not provide a gender comparison
as well as case reports, editorials, review articles, commen-
taries, practice guidelines, and studies of treatment com-
pliance and/or outcomes were excluded. Participants were
defined as persons with diagnosed or suspected TB, persons
from either the general population or high-risk populations
(e.g., HIV-infected, homeless, and prisoner), or health care
providers. Diagnosed TB included both pulmonary and
extrapulmonary forms, and TB diagnosis could be made
by sputum smear microscopy, culture, or chest X-ray using
histopathological or clinical criteria.
2.1.3. Study Selection Process. Following deduplication, stud-
ies were reviewed sequentially by title, abstract, and in full-
text form (Figure 1). At each stage, two reviewers indepen-
dently evaluated each study against study selection criteria.
Articleswereincludedorexcludedonlywhenbothreviewers
were in agreement, and conflicts were resolved by a third,
independentreviewer(AC,AG,orCRG).Toensuresufficient
concordance between reviewers, a pilot review and reviewer
discussion were conducted at each stage before proceeding
with the remaining studies. Six reviewers conducted the
t i t l es c r e e n( A D P ,J W D N ,N G ,S S ,T A ,a n dW T Y ) ,a n d
four reviewers conducted the abstract screen and the full-
text screen (ADP, JWDN, TA, and WTY). Following the
full-text screen, included articles underwent the full-text
assessment, which included data abstraction and a study
validity assessment.
2.1.4. Data Abstraction. Four reviewers (ADP, JWDN, TA,
and WTY) independently abstracted quantitative data from
each included full-text article in duplicate, and any conflicts
were resolved through discussion with a third, indepen-
dent reviewer (AG or CRG). Abstracted summary measures
included differences in means or proportions, risk ratios,
odds ratios, and hazards ratios.
2.1.5. Validity Assessment. We used validity assessment tools
to examine the quality of studies that inform our review;
the assessment was not used to exclude studies. We assessed
observational studies using items adopted from the methods
a n dr e s u l t ss e c t i o n so ft h eS t r e n g t h e n i n gt h eR e p o r t i n go f
Observational Studies in Epidemiology (STROBE) checklist
[148]. We used items adopted from the Consolidated Stan-
dards of Reporting Trials (CONSORT) checklist extension
for clustered randomized trials to assess an included clus-
tered randomized trial [149] and a pragmatic randomized
controlled trial [150]. Two reviewers independently assessed
the validity of each study using the adopted items (TA and
WTY), and conflicts were resolved through discussion and
arbitration with a third reviewer (CRG).
2.2. Outcomes and Definitions. Outcomes were quantitative
associationsbetweengenderandbothbarriersanddelaysthat
limit access to TB services along the full continuum of TB
care from symptom onset through diagnosis and treatment
initiation. Figure 2 presents the conceptual framework that
we used to define barriers and delays at the individual and
provider/system levels at various time points along the con-
tinuum of TB care. Individual-level barriers were defined to
be financial (the direct or indirect costs of TB care, including
costs of travel, diagnosis, and/or treatment as well as the
opportunity costs of lost employment, compensation, orTuberculosis Research and Treatment 3
Full-text articles assessed for 
eligibility
Records identified through database search
Records after duplicates removed
Title screen
Records excluded
Abstract screen
Records 
excluded
Studies with 
quantitative
components on 
barriers and delays
Full-text articles with quantitative components
excluded with the following reasons:
No assessment of TB healthcare utilization: (n=5 4 )
No sex-based comparisons: (n=4 2 )
Studies with qualitative components only (n=4 2 )
Multiple: (n=1 4 )
Studied on health-seeking only (n=9 )
Duplication: (n=8 )
No original data: (n=5 )
Not desired study design: (n=4 )
Unpublished study: (n=2 )
Unclear sex comparison: (n=1 )
Unclear methodology: (n=1 )
Not available: (n=1 )
Not peer-reviewed journal article: (n=1 )
(n = 323)
(n = 22,212)
(n = 13,448)
(n = 13,448)
(n = 12,549)
(n = 899)
(n = 576)
(n = 137) Not active TB: (n=1 )
Not clear if stigma is only related to TB: (n=1 )
Figure 1: Study selection process.
household work); physical (distance, travel logistics, and/or
accesstoTBcarefacilities);stigma(TB-specificsociocultural
barriers arising from community or individual prejudice
related to TB diagnosis or treatment, including social isola-
tion, marriage prospects, fertility concerns, and association
with HIV); health literacy (TB-related knowledge and edu-
cation); and sociodemographic (age, race, rural versus urban
residence, social caste, norms of practice, and social hierar-
chies). Provider-/system-level barriers were defined as any of
the following: provider degree of suspicion for TB, number4 Tuberculosis Research and Treatment
Individual
-level 
delay
Provider-/system-level delay
Symptom 
onset
Presentation 
to health 
facility
TB diagnosis 
suspected
Diagnosed 
with TB
TB 
treatment 
started
• Financial
• Physical
• Stigma
• Health literacy
• Sociodemographics
Individual-level 
barriers
• Provider’s degree of suspicion for TB
• Number of providers seen to be diagnosed with TB
• Provider’s adherence with national TB program guidelines
• Provider-patient interaction
• Patient’s waiting time
• Frequency of patients getting advice from providers
• Patient’s satisfaction with TB services
Provider-/
system-level 
barriers
Figure2:ConceptualframeworkillustratingbarriersanddelaysthatlimitaccesstoTBdiagnosticandtreatmentservices.Thefigureillustrates
the conceptual framework of the tuberculosis (TB) care continuum from symptom onset to treatment initiation that we used to define
barriers and delays that limit access to TB diagnostic and treatment services at the individual and provider/system levels. Individual-level
barriers impact access to TB services along the full continuum of TB care, and provider-/system-level barriers impact access to TB services
from patient presentation to any health care provider through TB treatment initiation. Barriers may contribute to delays between each step
along the TB care continuum. Accordingly, we define individual-level delay as the delay between symptom onset and presentation to any
health care provider; provider/system delay as the delay between presentation to any health care provider and diagnosis, the delay between
presentation to any health care provider and treatment initiation or the delay between diagnosis and treatment initiation; and combined
individual/provider/system delay as the delay between symptom onset and diagnosis or the delay between symptom onset and treatment
initiation.
of providers seen before TB diagnosis, provider adherence
to national TB program guidelines, provider-patient interac-
tion, patient waiting time, frequency of getting advice, and
patient satisfaction with TB services. Delay was defined as
any time period between points along the TB care pathway
under our conceptual framework from symptom onset to TB
treatment initiation (Figure 2). Although barriers and delays
are highly interrelated, few studies assess the contribution of
barriers to delays quantitatively. Therefore, we present results
forbarriersanddelaysseparately.Wepresentedtheimpactof
c e r t a i nb a r r i e r so nd e l a y sw h e n e v e rp o s s i b l e .
3. Results
3.1. Study Characteristics. Our search strategy yielded 13,448
citations. Of these, 323 articles were reviewed in full-text
form, and 137 studies met our selection criteria and were
included in our review (Figure 1). Among the included
studies, there was one (<1%)cluster-randomizedclinicaltrial
[91], one (<1%) pragmatic randomized controlled trial [55],
eight (6%) cohort studies [33, 37, 67, 68, 87, 92, 136, 137], one
(<1%) case-control study [69], and 126 (92%) cross-sectional
studies [12–32, 34–36, 38–54, 56–66, 70–86, 88–90, 93–135,
138–147,151].Moststudies(76%)assessedpersonspresenting
for care with diagnosed or suspected TB, and the median
sample size was 335 (IQR 190–1000) with women comprising
less than half of the study population (median, interquartile
range [IQR]: 42%, 34–49%). Most studies were published
between 2000 and 2010, and two-thirds were conducted in
Africa and Asia (Table 1).
3.2. Outcomes. Overall, the included studies reported
on gender-related barriers and delays at the individual,
provider/system, and combined individual/provider/system
levels. Specifically, 71 (52%) studies assessed individual-level
barriers, 19 (14%) studies assessed provider-/system-level
barriers, and 7 (5%) studies assessed combined individual-
/provider-/system-levelbarriers.Individual-leveldelayswere
assessed by 58 (42%) studies, 37 (27%) studies assessed
provider/system-level delays, and 25 (18%) studies assessed
combined individual-/provider-/system-level delays. Key
findings are summarized below by outcome type (barrier orTuberculosis Research and Treatment 5
Table 1: Characteristics of included studies.
Study characteristic Description
Study design: 𝑛 (%)
Clustered randomized trial: 1 (<1%);
pragmatic randomized clinical trial: 1
(<1%); cohort study: 8 (6%); case-control
study: 1 (<1%); cross-sectional study: 126
(92%)
Study population: 𝑛
(%)
Individuals with diagnosed/suspected TB
who presented to care: 76%; individuals
in the community or population: 24%
Year of publication:
𝑛 (%)
2000–2010: 123 (90%); 1990–1999: 11
(8%); 1980–1989: 2 (1%); 1970–1979: 1 (1%)
WHO regional
distribution: 𝑛 (%)
A F R O :3 7( 2 7 % ) ;S E A R O :3 1( 2 3 % ) ;
WPRO: 25 (18%); AMRO: 17 (13%);
EMRO: 12 (9%); EURO: 11 (8%); multiple
regions: 4 (3%)
Sample size Range: 39–209,560,379; median (IQR):
335 (190–1,000)
Proportion of
women
Range: 23–73%; median (IQR): 42%
(34–49%)
AFRO: African region; AMRO: region of the Americas; EMRO: Eastern
Mediterranean region; EURO: European region; IQR: interquartile range;
SEARO: South East Asia region; TB: tuberculosis; WHO: World Health
Organization; WPRO: Western Pacific region.
delay)andlevelofimpact(individual,provider/system,com-
bined individual/provider/system) (Table 2 and Supplemen-
tary Table S1).
3.3. Individual-Level Barriers
3.3.1. Financial. Of 137 studies, 21 (15%) examined gender-
related financial barriers to accessing TB services. Overall,
a large number of studies found that women faced more
financialbarrierstoseekingTBservicethanmen.Fewerstud-
ies found either no difference in financial barriers between
men and women or men faced greater financial barriers to
accessing care (e.g., the opportunity cost of lost wages or
income). While both men and women reported financial
barriers to seeking TB services, the nature of these barriers
differed.Womenweremorelikelytobefinanciallydependent
onothers[19,26],unemployed,orwithoutincome[16,17,20].
Womenalsoexperiencedgreaterhealthcareseekingcostsdue
t ot r a n s p o r to rt h en e e df o ra ne s c o r t[ 12, 17, 31], which may
impactawoman’sautonomyinseekingcare.Onestudyfound
that women may have also experienced greater financial
barriersthanmenbecausetheyweremorelikelytoseeprivate
providers than public providers [18]. The total direct costs
of seeking TB diagnostic services as a proportion of income
were higher for women than men in urban Zambia, largely
because women had lower monthly incomes than men [13].
In Malawi, the indirect household costs of seeking care were
higher for women [15].
3.3.2. Physical. Of 137 studies, only nine (7%) explored
gender-related physical barriers to accessing TB services. All
nine studies found that distance and travel time to a health
facilityweresimilarformenandwomen.However,onestudy
noted that distance to a clinic was more likely to result in
delayed diagnosis among women than men [14].
3.3.3.Stigma. Of137studies,18%investigatedgender-related
differences in TB-related stigma as a barrier to accessing
TB diagnostic and treatment services. Of these, 12 found no
gender-related differences in stigma, 11 found that women
reportedgreaterTB-relatedstigmathanmen,andtwostudies
found that men experienced greater TB-related stigma than
women.Onlytwostudiesspecificallyexaminedtheimpactof
TB-relatedstigmaongender-baseddifferencesinindividual-
level delays in seeking TB services; one study found that
the impact of stigma on delay was greater among women
than men [47], and the other study found no gender-based
difference [48]. Four studies examined the impact of TB-
related stigma on marriage and marital prospects, and all
reported that women were more likely than men to believe
th a tT Bw o ul dh a v ea na d v e r sei m pa cto nm a rria g ep r os pect s
and marriage [35, 39, 43, 44].
3.3.4. Health Literacy. Of 137 studies, 36% described gender-
related differences in TB-related knowledge and education as
barriers to accessing TB services, and the majority of these
(80%) examined differences in knowledge of the etiology,
transmission, symptoms, diagnosis, and/or treatment of TB.
Of the 39 studies that assessed TB-related health literacy,
18foundthatmenandwomenhadsimilarlevelsofTB-related
knowledge, and, among those, six were conducted strictly
in urban settings, and five were conducted in both urban
and rural settings. Fourteen studies found that men had
higher levels of TB-related knowledge than women; nine of
these were conducted in strictly rural settings, and four were
conducted in both rural and urban settings. Seven studies
foundthatwomenhadhigherlevelsofTB-relatedknowledge
than men; only one of these was conducted in a strictly
rural setting. In addition, among ten studies that examined
general educational attainment and literacy as barriers to
accessing TB services, seven found that men were more edu-
cated and/or had higher literacy rates than women, and the
remaining three studies found no gender-related differences.
Only two studies looked at the impact of TB-related
knowledge and education on individual-level delays in pre-
sentingtoTBservices;onefoundthatwomensufferedlonger
delays than men due to poor TB-related knowledge and
education [14], and one found no gender-related differences
[59]. One intervention trial found that, compared to women
who did not receive brief instruction before submitting
sputum samples, women who received instruction yielded
significantly increased rates of both sputum positivity and
return for submission of a second sputum sample. However,
no significant changes were found among men who received
such instruction [55]. This suggests that the intervention
removed poor knowledge as a barrier for women to provide
good sputum samples and to return for second sputum
submission. Among two studies that examined the impact of
TB-related knowledge on the likelihood of seeking tertiary-
level care, one found that TB-related knowledge was more
predictive of seeking hospital care among men than among
women[41],andonefoundnogender-relateddifference[61].6 Tuberculosis Research and Treatment
Table 2: Summary of quantitative gender-related findings by outcome type.
Outcome type
Number
of
studies
Gender difference No gender difference
Women > Men Men > Women
𝑛 (%) List of studies 𝑛 (%) List of studies 𝑛 (%) List of studies
Individual-level barriers
Financial 21
a 11 (52%) [12–14], [15]
a,
[16–22]
5 (24%) [23, 24], [15]
a,[ 25, 26] 6 (29%) [27–32]
Physical 9 1 (11%) [14] 8 (89%) [26, 30–36]
Stigma
b 25 11 (44%) [17,18,22,37–
44]
2 (8%) [45, 46] 12 (48%) [24–26, 35, 47–54]
Health literacy 49 17 (35%)
[26, 34–
36, 38, 41, 44,
50, 55–63]
8 (16%) [24, 28, 40, 42, 43, 64–
66]
24 (50%) [14, 20, 22, 25, 30, 37,
45–47, 51–53, 67–78]
Sociodemographic 6 4 (67%) [17, 79–81] 2( 3 3 % ) [36, 71]
Provider-/system- level
barriers 19 8( 4 2 % ) [17, 29, 37,
82–86]
11 (58%) [15, 28, 34, 35, 52, 73,
75, 87–90]
Combined individual-,
provider-, and
system-level barriers
7 5( 7 2 % ) [29, 91–94] 1 (14%) [95] 1 (14%) [18]
Individual-level delay 58 13 (22%)
[14, 17, 21, 51,
73, 79, 96–
102]
7( 1 2 % ) [37, 61, 103–107] 38 (66%)
[16, 18–20, 28, 30–
32, 36, 56, 71, 81, 108–
133]
Provider-/system-level
delay 37 11 (30%)
[14, 19, 20, 36,
81, 85, 120,
128, 131, 134,
135]
2( 5 % ) [35, 101] 24 (65%)
[16, 18, 32, 33, 79, 96,
99, 100, 104, 106, 107,
113, 115, 117, 118, 121,
122, 124, 132, 133, 136–
139]
Combined individual-,
provider-, and
system-level delay
25
c 9 (36%)
[140], [141]
c,
[27,32,36,79,
100, 142, 143]
1 (4%) [141]
c 17 (68%)
[33, 69, 110], [141]
c,
[35, 86, 114, 117, 124,
129, 131–133, 144–147]
aThis study is included in both gender difference categories as it reported that the direct costs of seeking care were higher for men and that the household costs
of seeking care were higher for women.
bOne study was not included because the direction of association between gender and stigma could not be assessed [30].
cThisstudyisincludedinallthreegender-relatedfindingcolumnsasitisamulticountrystudyandreportedgender-relatedfindingsthatdifferedfromcountry
to country.
3.3.5. Sociodemographic. Only six (4%) studies explored
gender-relateddifferencesinsociodemographicbarriers(fac-
tors of older age, family size, marital status, or caste) to
accessing TB services. Older women were more likely than
o lderm ent oei th erde la yo rn o tsee kca r e[79–81].Compared
to men, lower caste was more likely to predict individual-
level delays among women [80], but family size had no
gender-related differential impact on delays in seeking care
[36]. Two studies explored the impact of being unmarried,
separated, divorced, or widowed on seeking TB care [17, 71].
Among TB patients in Kenya, there was no gender-related
difference in the impact of marital status on seeking care for
TB [71]. However, in Bangladesh, women were more likely to
be adversely affected than men [17].
3.4. Provider-/System-Level Barriers. Of 137 studies, 19 (14%)
assessed gender-related barriers to accessing TB services at
the provider and system levels. Overall, these studies were
highly heterogeneous both in the barriers that were assessed
and the findings.
Barrierstoaccessingdiagnosticand/ortreatmentservices
at the provider and system levels were examined by nine
(47%) studies. Of these, eight studies examined gender-
related barriers to TB diagnosis and screening. In Thailand,
it was found that providers were more likely to adhere to
TB diagnostic guidelines among males with suspected TB
compared to females with suspected TB [83]. In Malawi,
malesandfemaleswithsuspectedTBmadeasimilarnumber
of visits to a health facility before being diagnosed with TB
[15, 90], and, in India, males and females with suspected
TB were offered sputum smear microscopy with similar
frequency [89]. In contrast, women in Gambia sought care
from a larger number of healthcare providers to obtain a TB
diagnosisthanmen[86],and,inVietnam,womentookmore
health-seekingactionsfortheirsymptomsthanmenbutwere
offered sputum smear examinations significantly less often
[21]. Among patients hospitalized and diagnosed with TB
i nt h eU n i t e dS t a t e s ,w o m e nf a c e dg r e a t e rp r o v i d e r - / s y s t e m -
level delays in undergoing sputum smear microscopy than
men [85] .H o w e v e r ,a m o n gH I V - i n f e c t e dp a t i e n t si nt h eTuberculosis Research and Treatment 7
United States, men and women were screened for TB with
similar frequency [87]. Only one study assessed gender-
related barriers to TB treatment following a diagnosis of TB
and found no differences between male and female patients
with respect to provider-related factors [28].
Gender-relateddifferencesinpatientsatisfactionwithTB
services were examined by seven (37%) studies [17, 34, 35, 37,
52, 73, 84]. In Nepal and Egypt, males and females with sus-
pected TB had similar levels of satisfaction with TB services
[34, 35]. However, women in Egypt were less satisfied with
drug availability than men, and women in Bangladesh and
Syria were less satisfied with TB clinic hours, providers, and
servicesthanmen,allofwhichwerealsopredictorsofhealth-
seeking [17, 35, 37]. Compared to men, a greater proportion
of women in Tanzania reported that a good provider-patient
relationship was an important factor in their satisfaction
with TB services [73]. Vietnamese TB patients reported
no gender-related differences in the health education they
received about their disease [52]. In another Tanzanian study
where patientswere randomizedto community-basedversus
clinic-based TB treatment, male patients were more satisfied
with community-based treatment than female patients [84].
Divided opinion regarding venue of treatment was noted
i nt h es t u d y .S o m ep a t i e n t sp r e f e r r e dc o m m u n i t y - b a s e d
treatmentduetoconvenience,reducedtransportcosts,saved
time,andreducedlostwages,whereasotherspreferredclinic-
based treatment because it led to greater access to other
clinical services and health education [84].
The remaining three studies reported on gender-related
differences in health literacy among providers and TB-
related hospitalization. Two studies assessed gender-based
differences in TB-related knowledge among health workers
and found no gender-based differences among providers in
Oman and Iraq where patients may be more likely to seek
care from providers of the same sex [75, 88]. One study in
T a j i k i s t a nf o u n dt h a tm a l eT Bp a t i e n t sw e r em o r el i k e l yt o
be hospitalized for treatment than female TB patients; other
predictors of hospitalization in this study included positive
sputum smear and availability of hospital beds [82].
3.5. Combined Individual-/Provider-/System-Level Barriers.
Seven (5%) studies assessed gender-related differences in
TB case detection rates, which were impacted by combined
individual-/provider-/system-level barriers. Community-
b a s e da c t i v ec a s efi n d i n gw a so n es t r a t e g yu s e dt oo v e r c o m e
combined level barriers to accessing TB diagnostic services
[152, 153]. Seven studies compared community-based active
case finding versus passive case finding (i.e., self-referral). Of
these, five found that community-based active case finding
increased TB case detection rates more significantly among
women than men [29, 91–94]; one found greater increases
in case detection rates among men than women [95]; and
one found no difference in the change of case detection rates
between men and women [18].
3.6. Individual-Level Delays. Almost half of the included
studies (42%) appraised gender-related differences in indi-
vidual-level delays. Of these, 38 found that symptomatic
w o m e nw e r ea sl i k e l ya ss y m p t o m a t i cm e nt od e l a yo r
not seek TB services. However, among the 20 studies that
found gender-related differences, 13 found that symptomatic
womenweremorelikelytodela yornotseekTBservicesthan
symptomaticmen,whereas seven studies foundthatsympto-
matic women were less likely to delay or not seek TB ser-
vices than symptomatic men. The majority of studies were
performed among study populations of persons who had
already presented for care with diagnosed or suspected TB.
Only five studies assessed persons with suspected TB in the
general population. Of these, one study found that women
were quicker to seek care for a prolonged cough [61], two
studies found that women were slower to seek care [21, 97],
and two studies found no difference in delay by gender [56,
111].
3.7. Provider-/System-Level Delays. Of 137 studies, 37 (27%)
assessed gender-related differences in provider-/system-level
delays in accessing TB services. The time between the
presentation of a person with suspected TB to a health
facility and TB diagnosis was most commonly assessed. Of
22 studies, 55% found no gender-related difference in the
delay from presentation to TB diagnosis. All of the remain-
ing 10 studies found that women experienced longer delays
than men. Among 13 studies that examined the delay from
presentation to TB treatment initiation, nine found no
gender-relateddifference,threefoundthatwomenhadlonger
delays than men [14, 81, 135], and only one study found that
men experienced longer delays than women [101]. Similarly,
among seven studies that measured the delay between TB
diagnosisand TB treatmentinitiation,fourfoundno gender-
related difference [33, 79, 104, 137], two found that women
had longer delays than men [14, 19], and only one found that
men had longer delays than women [35].
3.8.CombinedIndividual-/Provider-/System-LevelDelays. Of
137 studies, 25 (18%) reported on gender-related differences
in combined individual-/provider-/system-level delays. The
delay between symptom onset and TB treatment initiation
was most commonly assessed, and 13 out of these 18 (68%)
studies found no gender-related difference. When a gender-
related difference was observed, women faced longer delays
than men [27, 79, 100, 140, 143]. One multicountry study
found that, compared to men, women experienced longer
delaysinYemenandshorterdelaysinEgyptbutsimilardelays
in other countries [141]. Among nine studies that assessed
gender-related differences in the delay between symptom
onset and TB diagnosis, 5 found no gender-related difference
[33, 35, 114, 133, 146], whereas four studies found that women
experienced longer delays than men [32, 36, 79, 142].
3.9. Quality of Included Studies. We assessed 126 cross-sec-
tional studies, one case-control study, and eight cohort stud-
ies using the STROBE criteria [148], and we assessed two
randomized trials using the CONSORT criteria [149, 150].
The majority of studies suffered from poor quality report-
ing of research design, methods, analyses, and results (see
Supplementary Tables S2 and S3). Key weaknesses specific
to and pervasive among the cross-sectional studies (92% of
included studies) were inadequate reporting regarding the8 Tuberculosis Research and Treatment
numbers of males and females at each study stage from eligi-
bility assessment through enrollment, participation, follow-
up, and analysis; explanation of nonparticipation for males
and females at each stage; information on prevalence of
exposures and confounders among the male and female
participants; presentation of unadjusted and confounder-
adjustedestimatesformalesandfemales;andexplanationfor
selection of confounders for adjustment.
4. Discussion
Guided by a systematic review process, our review aimed to
assessthequantitativeevidenceforgender-relateddifferences
in the barriers and delays that impact access to TB diagnostic
and treatment services at the individual and provider/system
levels. While, collectively, the included studies reported on
barriers and delays at each level, more studies examined
individual-level barriers and delays, and most studies sur-
veyed persons presenting for care with diagnosed or sus-
p e c t e dT Ba n dw e r ec o n d u c t e di nA f r i c aa n dA s i a .O v e r a l l ,
our review identified that many studies found no quantita-
tive gender-related differences. However, when differences
were reported, more studies found that women experienced
greater barriers and longer delays at each level than men. In
particular, many studies reported gender-related differences
in financial, stigma, and health literacy barriers, which
are interrelated and represent potential targets for gender-
specific interventions that may be integrated into current and
future TB service strategies.
While both genders experienced financial barriers to
accessing TB services, the majority of studies that found
gender-related differences reported that women experienced
greaterfinancialbarriersthanmen,andtheidentifiedbarriers
were gender-specific. Specifically, the male role of primary
income earner in many households prevented men from
leaving work to access TB services, whereas, for women,
their financial dependence on spouses and families limited
access to TB services. Similar gender-related differences
have been observed in financial barriers that limit access
to diagnostic and treatment services for HIV and malaria
[154–157]. Instituting more flexible hours and locations for
TB services may help overcome the opportunity cost of
lost wages and may improve case detection and treatment
initiation among men. For women, barriers due to financial
dependence may be compounded by the deprioritization of
women’s health care within the household below the needs of
men and children. Because maternal health is prioritized by
some households [158], efforts to integrate TB services with
maternal healthcare may overcome some financial barriers
and facilitate access to TB services among some women.
Regarding TB-related stigma, our review found that
women were fearful of having a diagnosis of TB disclosed
to their spouse, family, or community. Women experienced
greater stigma than men, when gender-related differences
were found. The impact of disease-related stigma has been
well studied in the context of HIV, where anticipated or
experienced stigma may lead patients to conceal symptoms,
avoid or delay seeking care, hide their diagnoses, and be
nonadherent with treatment [159–163]. Specifically, TB has
been associated with dirtiness, immorality, substance abuse,
and sexual promiscuity or deviancy [164–166], and, in com-
munities with high rates of TB/HIV coinfection, TB may
be further stigmatized by its association with HIV [167]. In
addition to the psychosocial consequences of a TB diagnosis,
our review also found that women were concerned about
marital prospects and rejection by their spouse or families.
Thus, TB-related stigma may also manifest as a financial
barrier among those women who depend on spouses and
family for financial support.
While stigma barriers may be addressed by interventions
to improve TB-related health literacy, our review suggests
that such programs may be particularly beneficial for women
in rural areas. Among the included studies that reported
gender difference in TB-related knowledge, men had greater
TB-related knowledge and higher general literacy rates than
women, and the majority of these (64%) were conducted in
rural settings. It may be important to examine the interac-
tion between female literacy and the impact of poverty on
c a r es e e k i n ga st h i si n t e r a c t i o nh a si m p a c t e dc a r es e e k i n g
among women in the context of other health services [168,
169].
Although only a few studies assessed the impact of
barriers on delays, individual-level barriers appear to impact
individual-level delays in TB care seeking in gender-specific
ways. Symptomatic women were more likely to delay or not
seek care than symptomatic men when gender-related dif-
ferences in individual-level delays were reported. Individual-
level TB-related stigma can represent both an obstacle and
am o t i v a t i o nt os e e k i n gc a r e[ 48], and marital status, which
is intimately interlinked with issues of financial and social
dependency as well as spousal and family support or rejec-
tion, also had a variable impact on gender-related differences
in access to services [17, 71]. Regarding sociodemographic
barriers, older age was a more significant barrier to accessing
TB services among women than men [79, 81]. Given the
complexityoftheserelationships,itisimportanttogobeyond
comparing the frequency and severity of individual-level
barriers among women and men. Researchers and policy-
makers must also understand the impact of individual-level
barriers on individual-level delays and how these barriers
cause delays in accessing TB services among women and
men.Qualitativestudiesmayplayaninvaluablerolehereand
informresearchersonthemechanismsofbarriersanddelays,
which can be the points of intervention in the future.
Similarly, it is important to understand gender-related
differences in provider-/system-level barriers and delays. In
our review, fewer studies assessed barriers and delays at the
provider/systemlevel.However,whendisparitieswerefound,
w o m e nw e r em o r el i k e l yt of a c eb a r r i e r st oa c c e s s i n gT B
services than men. In addition, gender-specific individual
barriers, such as financial and stigma barriers, may also
impacttheprovider/systemlevelbutwerenotassessedbythe
studies included in our review. Surprisingly, in the context
of other diseases, there are few reports on gender-related
disparities in barriers and delays that limit access to care,
particularly at the provider/system levels among patients
in resource-limited settings. Provider-/system-level barriers
and delays that lead to gender-related disparities in healthTuberculosis Research and Treatment 9
often result from the lack of attention to the different needs
of men and women while planning and providing health
services, particularly with respect to service availability (e.g.,
geographicallocation,transportationavailable,servicehours,
and waiting time), affordability, acceptability (e.g., social and
cultural competency, respect, privacy, confidentiality, and
autonomy),andaccountability[170,171].Furthermore,health
providersandhealthsystemsmaycompoundindividual-level
and community-level disparities by failing to recognize that
gender-based differences exist or by failing to acknowledge
the need for corrective interventions [1].
In addition to the paucity of data on barriers and
delays at the provider/system levels, our review revealed sev-
eralotherresearchgaps.Tocomprehensivelyidentifygender-
relatedbarriersanddelays,studypopulationsneedtoinclude
persons with suspected TB who have not presented for care.
There is also an urgent need for more granular analyses
of gender disparities in accessing TB services for each step
alongthediagnosticandtreatmentcontinuum(i.e.,symptom
onset to symptom recognition; symptom recognition to
seeking care; seeking care to TB diagnosis; TB diagnosis to
notification; and notification to treatment initiation) at all
levels. More generally, prospectively designed gender ana-
lysesareneeded,andstandardizedethnographicandcultural
epidemiologic tools [5] also need to be used prospectively
to systematically collect and compare gender-related socio-
cultural variables across studies, which may help to identify
common as well as unique gender-related barriers.
The studies included in our review span different con-
tinents and differ among degree of urbanization and type
of study population. Therefore, it is important to recognize
heterogeneity while summarizing our findings. While most
o ft h ei n c l u d e ds t u d i e sw e r ec o n d u c t e di nt h eA f r i c a ,S o u t h
East Asia, and West Pacific regions, the frequency of some
reported barriers by gender was not always proportional to
numbersofstudiesfromtheseregions.Forexample,financial
barriers and delays at the individual and provider/system
levels were reported proportionally by region, regardless of
gender. However, women in South East Asia were noted
to face more stigma, and women in West Pacific and both
men and women in South East Asia had lower health
literacy than persons from Africa (see Supplementary Table
S4). These findings implicate region-specific priorities in
interventions to improve access to TB care. Regarding study
population type, included studies that assessed the general
population (one quarter of the included studies) almost
exclusively reported on stigma and health literacy barriers.
Compared to studies among persons with diagnosed or sus-
pectedTBthatfoundgenderdisparities,studiesthatassessed
the general population were less likely to report that women
face greater stigma and more likely to report that women
have lower health literacy than men (see Supplementary
Table S5). There is very little data to assess barriers and
delays in different degrees of urbanization, as high percent-
age of studies were conducted in mixed urban and rural
setting. However, studies from rural areas more frequently
reported on worse health literacy among women (see Sup-
plementary Table S6). The implication was already discussed
above.
Many have called for more research on gender-related
disparitiesinTB[4,5,8,172,173].Accordingly,oursystematic
review aimed to assess the quantitative gender-related differ-
encesinbarriersanddelays thatlimitaccess toTBdiagnostic
and treatment services, which have been recognized as
important for optimal TB control. However, a number of
b i a s e sm a yh a v ei m p a c t e do u rr e s u l t sa n dt h ei n d i v i d u a l
studies that were included in our review. Although we strove
to capture all high-quality studies addressing the topic of
t h i sr e v i e w ,s o m es t u d i e sm a yh a v eb e e nm i s s e d ,p a r t i c u l a r l y
those that were not published because they failed to doc-
ument gender-related differences in accessing TB services,
which may have resulted in an over representation of studies
that demonstrated a difference (i.e., publication bias). In
addition, our review was subject to biases introduced by the
exclusion of non-English articles as studies from countries
where English is not a primary language, particularly Latin
AmericancountriesorEastAsia,maybeunderrepresented.A
noted limitationof the included studies was that the majority
was cross-sectional studies and assessed patients with a
confirmed TB diagnosis and/or those presenting for TB care.
Those experiencing the greatest barriers to TB services are
alsoleastlikelytobediagnosedwithTB.Becausepersonspre-
senting for care have already surmounted many individual-
level barriers, comparisons of gender-related differences in
these study populations will suffer from selection bias. In
addition, sample size among the included studies was highly
variable, and the quality of study reporting was generally
poor .Finally ,thesummarymeasuresanddefinitionsofbarri-
ers and delays were inconsistently used, making it difficult to
weigh the relative importance of findings from the included
studies or to conduct a meta-analysis or stratified analysis.
5. Conclusions
Overall, the scientific community is recognizing that gender-
related differences in health may be greater than is known
and is increasingly prioritizing the need for routine gender-
related analyses [174–177]. Notably, the WHO has developed
a strategy to mainstream the analysis of the role of gender
in health and to monitor and address systemic gender-
related health inequities [178]. In the context of TB, gender
analyses are critical to inform interventions to optimize the
globalimpactofTBservices.Oursystematicreviewindicated
that, when gender-related differences were found, women
experienced greater barriers and longer delays than men
and identified several gender-specific components within
individual-level financial, stigma, and health literacy barriers
that are amenable to intervention. However, our review also
revealed research gaps and clearly highlighted that well-
designed gender analyses are critical. Finally, qualitative
accounts of the gender differences presented here would
inform mechanisms of barriers and provide insight for
interventions.
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